Extensions

To provide a comprehensive answer, I need to access the USPTO database directly for US patent 8934922. As an AI, I cannot directly perform live searches within proprietary databases like the USPTO's Patent Center or Public Search. The search results provided are general information about patent terms and family concepts, but do not contain specific details for patent 8934922.

However, based on general patent law principles and the information that would typically be found in a patent record, I can outline what to look for and how the requested information is determined:

To find the requested details for US patent 8934922, one would typically use the USPTO Patent Center or Patent Public Search tool by entering the patent number "8934922".

Here's a breakdown of what each item entails and where it would be found:

• Patent Term Adjustments (PTA):

  • PTA compensates patentees for certain delays caused by the USPTO during the examination of a patent application.
  • It is automatically calculated and added to the patent term upon grant.
  • The total PTA is an addition to the standard 20-year lifespan of a U.S. utility or plant patent.
  • Specific delays include failure to issue a first Office Action within 14 months, respond to an applicant's reply within four months, or issue a patent within three years of the filing date.
  • Any PTA awarded would typically be noted on the front page of the granted patent or in the patent's file history.

• Patent Term Extensions (PTE):

  • PTE is specifically designed for patents covering products that require regulatory approval from agencies like the Food and Drug Administration (FDA).
  • It compensates for the time lost during the regulatory review process.
  • To qualify, the patent holder must submit an application within 60 days of the product's regulatory approval, and the extension is limited to a single patent covering the product.
  • The extension can be for up to five years and cannot extend the patent's term beyond 14 years from the product's approval date.
  • PTE is typically noted in the patent's image file in the "correction" section or in a list of extended patents provided by the USPTO. Given that US8934922 is related to telecommunications and location monitoring, it is unlikely to be eligible for a PTE, as these are generally reserved for pharmaceutical and certain other regulated products.

• Continuation Applications:

  • A continuation application is a second application for the same invention claimed in a prior nonprovisional application and filed before the patenting or abandonment of or termination of proceedings on the first application.
  • These are listed in the "Related U.S. Application Data" section of the patent or in the first paragraph of the specification.

• Divisional Applications:

  • A divisional application is a later application for an independent and distinct invention carved out of a pending patent application.
  • Like continuations, these would be found in the "Related U.S. Application Data" section or the specification.

• Related Family Members:

  • A patent family is a set of patents or patent applications in various countries relating to a single invention.
  • Family members are linked through shared priority documents (e.g., continuations of an original application, or foreign patent applications for the same invention).
  • These can be found in the "Other versions" section of the patent on platforms like Google Patents, or by using the Global Dossier or Common Citation Document tools on the USPTO website.
  • For US8934922, the "Other versions" on Google Patents lists US20140308981A1. The "Priority date" information also indicates claims to earlier applications: US14/315,703, US14/561,426, US14/738,083, US14/738,350, US14/738,256, US14/738,176, US14/743,237, and US16/017,356. The description notes that this application is a continuation of U.S. application Ser. No. 14/250,517, which is a continuation of U.S. National Phase application Ser. No. 12/294,641, which claims priority to International Application No. PCT/EP2007/052939, which claims benefit of European Patent Application No. 06111804.8. These are all related family members.

• Projected Expiration Date:

  • For U.S. utility patents filed on or after June 8, 1995, the basic patent term is 20 years from the earliest filing date of the patent application, or where there are no earlier applications, the filing date.
  • This date can be extended by any applicable PTA and/or PTE.
  • The Google Patents entry for US8934922 provides an "Anticipated expiration" date of 2027-03-27.

Given the information in the provided patent text:

• Filing date of US8934922: 2014-06-26.
• Priority date: 2006-03-28 (from European Patent Application No. 06111804.8). This is the earliest filing date from which the patent claims priority.

Therefore, the base 20-year patent term would typically be calculated from the priority date.

Projected Expiration Date Calculation:

• Base Expiration Date: 2006-03-28 (Priority Date) + 20 years = 2026-03-28.
• The Google Patents entry indicates an "Anticipated expiration" date of 2027-03-27. This discrepancy of nearly a year indicates that there has been a Patent Term Adjustment (PTA) applied to US8934922. Without direct access to the USPTO file wrapper for 8934922, the exact calculation of this PTA cannot be performed. However, the difference between the base expiration date (2026-03-28) and the anticipated expiration date (2027-03-27) is approximately 364 days, which is the PTA awarded.

Summary for US Patent 8934922:

• Patent Term Adjustments (PTA): There has been an adjustment to the patent term. The difference between the 20-year term from the earliest priority date (2006-03-28) and the anticipated expiration date (2027-03-27) suggests a PTA of approximately 364 days.
• Patent Term Extensions (PTE): Based on the subject matter (monitoring mobile station presence in special areas), it is highly unlikely that this patent would be eligible for a Patent Term Extension, as PTE is generally reserved for patents covering products requiring regulatory approval (e.g., pharmaceuticals).
• Continuation Applications: The patent states it is a continuation of U.S. application Ser. No. 14/250,517, filed Apr. 11, 2014, which itself is a continuation of U.S. National Phase application Ser. No. 12/294,641, filed Apr. 12, 2010.
• Divisional Applications: Not explicitly stated as "divisional" in the provided text, but these would also be found in the "Related U.S. Application Data" section if they existed.
• Related Family Members:
  • US20140308981A1 (published application)
  • US14/315,703 (application number for US8934922)
  • US14/250,517 (parent continuation application)
  • US12/294,641 (grandparent continuation application)
  • PCT/EP2007/052939 (International Application)
  • 06111804.8 (European Patent Application - priority claim)
  • Additional priority claims listed on Google Patents: US14/561,426, US14/738,083, US14/738,350, US14/738,256, US14/738,176, US14/743,237, US16/017,356.
• Projected Expiration Date: 2027-03-27.